Plasminogen activators are not required in the erythrocytic life cycle of malaria parasites

Molecular and Biochemical Parasitology

Volumn 97, Issue 1-2, 1998, Pages 253-257

  Rosenthal, Philip J ^a   Semenov, Andrey ^a   Ploplis, Victoria A ^b   Plow, Edward F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Malaria; Plasminogen; Plasmodium; Protease; Proteinase

Indexed keywords

PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; MALARIA; MEROZOITE; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM VINCKEI; PRIORITY JOURNAL;

ANIMALS; ERYTHROCYTES; HUMANS; LIFE CYCLE STAGES; MICE; MICE, KNOCKOUT; PLASMINOGEN; PLASMINOGEN ACTIVATORS; PLASMODIUM; PROTOZOAN PROTEINS;

PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM VINCKEI;

EID: 0032583157     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(98)00142-X     Document Type: Article

References (28)

1. McKerrow J.H., Sun E., Rosenthal P.J., Bouvier J. The proteases and pathogenicity of parasitic protozoa. Annu. Rev. Microbiol. 47:1993;821-853.
2. Rosenthal P.J. Proteases of malaria parasites: new targets for chemotherapy. Emerg. Infect. Dis. 4:1998;49-57.
3. 33 as a noncovalently associated complex with other fragments of the MSP1. Mol. Biochem. Parasitol. 50:1992;307-316.
4. Blackman M.J., Fujioka H., Stafford W.H.L., Sajid M., Clough B., Fleck S.L., Aikawa M., Grainger M., Hackett F. A subtilisin-like protein in secretory organelles of Plasmodium falciparum merozoites. J. Biol. Chem. 273:1998;23398-23409.
5. Roggwiller E., Fricaud A.-C., Blisnick T., Braun-Breton C. Host urokinase-type plasminogen activator participates in the release of malaria merozoites from infected erythrocytes. Mol. Biochem. Parasitol. 86:1997;49-59.
6. Jandl JH. Blood. Boston: Little, Brown and Company, 1996.
7. Vassalli J.D., Sappino A.P., Belin D. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1991;1067-1072.
8. Plow E.F., Herren T., Redlitz A., Miles L.A., Hoover-Plow J.L. The cell biology of the plasminogen system. FASEB J. 9:1995;939-945.
9. Vaughn DE, Schafer AI, Loscalzo J. Normal mechanisms of hemostasis and fibrinolysis. In: Loscalzo J, Creager MA, Dzau VJ, editors. Vascular Medicine. Boston: Little, Brown and Company, 1996:207-216.
10. Aoki N., Harpel P.C. Inhibitors of the fibrinolytic enzyme system. Semin. Thromb. Hemost. 10:1984;24-41.
11. Gettins P., Patston P.A., Schapira M. Structure and mechanism of action of serpins. Hematol. Oncol. Clin. North Am. 6:1992;1393-1408.
12. Chapman H.A. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9:1997;714-724.
13. Sodeinde O.A., Subrahmanyam Y.V., Stark K., Quan T., Bao Y., Goguen J.D. A surface protease and the invasive character of plague. Science. 258:1992;1004-1007.
14. Mitra M.M., Alizadeh H., Gerard R.D., Niederkorn J.Y. Characterization of a plasminogen activator produced by Acanthamoeba castellanii. Mol. Biochem. Parasitol. 73:1995;157-164.
15. Boyle M.D., Lottenberg R. Plasminogen activation by invasive human pathogens. Thromb. Haemost. 77:1997;1-10.
16. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 193:1976;673-675.
17. Lambros C., Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:1979;418-420.
18. Rosenthal P.J., Olson J.E., Lee G.K., Palmer J.T., Klaus J.L., Rasnick D. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob. Agents Chemother. 40:1996;1600-1603.
19. Berkenpas M.B., Lawrence D.A., Ginsburg D. Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J. 14:1995;2969-2977.
20. Hajjar K.A. Cellular receptors in the regulation of plasmin generation. Thromb. Haemost. 74:1995;294-301.
21. Carmeliet P., Schoonjans L., Kieckens L. et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 368:1994;419-424.
22. Ploplis V.A., Carmeliet P., Vazirzadeh S. et al. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation. 92:1995;2585-2593.
23. Dewerchin M., Nuffelen A.V., Wallays G. et al. Generation and characterization of urokinase receptor-deficient mice. J. Clin. Invest. 97:1996;870-878.
24. Killick-Kendrick R, Peters W, editors. Rodent Malaria. London: Academic Press, 1978.
25. Banyal H.S., Misra G.C., Gupta C.M., Dutta G.P. Involvement of malarial proteases in the interaction between the parasite and host erythrocyte in Plasmodium knowlesi infections. J. Parasitol. 67:1981;623-626.
26. Hadley T., Aikawa M., Miller L.H. Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors. Exp. Parasitol. 55:1983;306-311.
27. Dejkriengkraikhul P., Wilairat P. Requirement of malarial protease in the invasion of human red cells by merozoites of Plasmodium falciparum. Z. Parasitenkd. 69:1983;313-317.
28. Dluzewski A.R., Rangachari K., Wilson R.J.M., Gratzer W.B. Plasmodium falciparum: protease inhibitors and inhibition of erythrocyte invasion. Exp. Parasitol. 62:1986;416-422.